Northwestern Mutual Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3
Closed 3167
2022
Q1
$0 Sell
3
-17
-85% -$484 ﹤0.01% 3098
2021
Q4
$1K Buy
+20
New +$1.11K ﹤0.01% 3001
2019
Q4
Sell
-60
Closed -$11K 2385
2019
Q3
$11K Hold
60
﹤0.01% 1892
2019
Q2
$14K Buy
+60
New +$11.7K ﹤0.01% 1835
2013
Q3
Sell
-1,000
Closed -$81K 1345
2013
Q2
$81K Buy
+1,000
New +$74.2K ﹤0.01% 475

Other funds holding AXDX

Northwestern Mutual Wealth Management's AXDX Position: Q2 2022 in Review

Northwestern Mutual Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 3 shares.

Northwestern Mutual Wealth Management first reported a position in AXDX in Q2 2013 and held it in 5 quarters. The position peaked at $81K in Q2 2013. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Northwestern Mutual Wealth Management reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 3 Accelerate Diagnostics shares in Q2 2022.
  • Northwestern Mutual Wealth Management first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Accelerate Diagnostics position peaked at $81K in Q2 2013.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.